Correction: Preclinical Development of Ipilimumab and Nivolumab Combination Immunotherapy: Mouse Tumor Models, In Vitro Functional Studies, and Cynomolgus Macaque Toxicology.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 27861630.
- Also identified by DOI 10.1371/journal.pone.0167251 and PMC identifier 5115859.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
[This corrects the article DOI: 10.1371/journal.pone.0161779.].